Citizens Financial Group Inc Eli Lilly & CO Transaction History

Citizens Financial Group Inc

$4.91 Billion
Q3 2024

A detailed history of Citizens Financial Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Citizens Financial Group Inc holds 50,575 shares of LLY stock, worth $37.7 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

50,575

Previous 53,087 4.73%

Holding current value

$37.7 Million

Previous $48.1 Million 6.78%

% of portfolio

0.91%

Previous 1.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $1.94 Million - $2.41 Million	-2,512 Reduced 4.73%	50,575 $44.8 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $9.78 Million - $12.3 Million	13,488 Added 34.06%	53,087 $48.1 Million
Q1 2024 May 17, 2024	BUY	$592.2 - $792.28 $201,348 - $269,375	340 Added 0.87%	39,599 $30.8 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $644,408 - $759,672	1,227 Added 3.23%	39,259 $22.9 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $692,477 - $954,684	-1,593 Reduced 4.02%	38,032 $20.4 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $1.15 Million - $1.54 Million	-3,285 Reduced 7.66%	39,625 $18.6 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $365,300 - $429,028	1,176 Added 2.82%	42,910 $14.7 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $6.23 Million - $7.26 Million	-19,376 Reduced 31.71%	41,734 $15.3 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $254,083 - $289,554	-857 Reduced 1.38%	61,110 $19.8 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $401,928 - $471,923	-1,442 Reduced 2.27%	61,967 $20.1 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $195,731 - $243,244	-834 Reduced 1.3%	63,409 $18.2 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $324,233 - $402,375	-1,442 Reduced 2.2%	64,243 $17.7 Million
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $395,556 - $486,787	1,785 Added 2.79%	65,685 $15.2 Million
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $23,110 - $29,893	-128 Reduced 0.2%	63,900 $14.7 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $33,192 - $42,969	202 Added 0.32%	64,028 $12 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $372,071 - $492,340	-2,852 Reduced 4.28%	63,826 $10.8 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $388,652 - $449,547	2,658 Added 4.15%	66,678 $9.86 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $145,014 - $174,523	-1,063 Reduced 1.63%	64,020 $10.5 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $410,127 - $507,620	-3,445 Reduced 5.03%	65,083 $9.03 Million
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $330,703 - $409,605	-3,093 Reduced 4.32%	68,528 $9.01 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $126,012 - $137,068	-1,180 Reduced 1.62%	71,621 $8.01 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $164,079 - $191,522	-1,481 Reduced 1.99%	72,801 $8.07 Million
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $262,468 - $308,945	2,358 Added 3.28%	74,282 $9.64 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $15,567 - $17,440	-147 Reduced 0.2%	71,924 $8.32 Million
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $69,460 - $86,813	-809 Reduced 1.11%	72,071 $7.73 Million
Q2 2018 Jul 27, 2018	BUY	$75.7 - $86.88 $4.94 Million - $5.67 Million	65,247 Added 854.8%	72,880 $6.22 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $10,463 - $12,351	-141 Reduced 1.81%	7,633 $591,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $21,714 - $23,290	-265 Reduced 3.3%	7,774 $657,000
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $148,976 - $165,348	-1,933 Reduced 19.38%	8,039 $688,000
Q2 2017 Aug 10, 2017	BUY	N/A	9,972	9,972 $820,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account

Citizens Financial Group Inc Eli Lilly & CO Transaction History